Emergent BioSolutions provides contract manufacturing services for both bulk drug substances and sterile injectable drug products. Our state-of-the-art, single-use BDS facility enables turnkey upstream and downstream support for microbial, mammalian, and viral cell lines. Our Fill/Finish services include vials and syringes for both liquid and lyophilized products. We also offer lyo cycle development and optimization. Our global manufacturing network currently produces over 30 commercial products and supports a host of clinical stage programs.